DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial

BACKGROUND: Children are susceptible to severe influenza infections and facilitate community transmission. One potential strategy to improve vaccine immunogenicity in children against seasonal influenza involves a trivalent hemagglutinin DNA prime-trivalent inactivated influenza vaccine (IIV3) boost...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:PLoS One
Huvudupphovsmän: Houser, Katherine V., Yamshchikov, Galina V., Bellamy, Abbie R., May, Jeanine, Enama, Mary E., Sarwar, Uzma, Larkin, Brenda, Bailer, Robert T., Koup, Richard, Paskel, Myeisha, Subbarao, Kanta, Anderson, Edwin, Bernstein, David I., Creech, Buddy, Keyserling, Harry, Spearman, Paul, Wright, Peter F., Graham, Barney S., Ledgerwood, Julie E.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Public Library of Science 2018
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6214651/
https://ncbi.nlm.nih.gov/pubmed/30388160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0206837
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk